John K. Clarke's Insider Trades & SAST Disclosures
John K. Clarke's most recent trade in Atyr Pharma Inc was a trade of 24,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 22, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John K. Clarke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atyr Pharma Inc | John K. Clarke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,000 | 0 | - | - | Restricted Stock Unit | |
| Atyr Pharma Inc | John K. Clarke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,000 | 19,797 (0%) | 0% | - | Common Stock | |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 6,000 | 6,000 | - | - | Restricted Stock Units | |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.34 per share. | 21 May 2021 | 2,500 | 108,083 (1%) | 0% | 4.3 | 10,850 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 1,428 | 1,428 | - | - | Stock Option (right to buy) | |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 28 Aug 2020 | 7,260 | 110,583 (1%) | 0% | 4.0 | 29,113 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 28 Aug 2020 | 100 | 117,843 (1%) | 0% | 4 | 400 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.09 per share. | 26 Aug 2020 | 5,440 | 117,943 (1%) | 0% | 4.1 | 22,250 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.30 per share. | 26 Aug 2020 | 2,200 | 123,383 (1%) | 0% | 4.3 | 9,451 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 1,428 | 1,428 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges